This result is consistent with previous findings that MSCs exhibit a chemotactic response to CCL25 [39, 40], indicating that the expression of CCL25 from micrometastatic regions might be a leading driver of MSC recruitment to tumor sites. This evidence concerns the gene CCL25 and neoplasm.